Calendar

pharmadog

Week of Nov 9, 2020

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 9, 2020approval2102d agoOLANZAPINE — FDA approvalolanzapine ODT

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →olanzapine ODT →fda approvals ↗

Nov 10, 2020approval2101d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗

Nov 10, 2020approval2101d agoOPDIVO (NIVOLUMAB) — FDA approvalnivolumab

Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION

full page →nivolumab →fda approvals ↗

Nov 10, 2020approval2101d agoXYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approvalSanofi

Sponsor: CHATTEM SANOFI. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Nov 10, 2020approval2101d agoIMFINZI (DURVALUMAB) — FDA approvalASTRAZENECA PLC

Sponsor: ASTRAZENECA UK LTD. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Nov 10, 2020approval2101d agoTECENTRIQ (ATEZOLIZUMAB) — FDA approvalatezolizumab

Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION

full page →atezolizumab →fda approvals ↗

Nov 10, 2020approval2101d agoLIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalcemiplimab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS

full page →cemiplimab →fda approvals ↗

Nov 10, 2020approval2101d agoTACROLIMUS — FDA approvaltacrolimus ER

Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL

full page →tacrolimus ER →fda approvals ↗

Nov 10, 2020approval2101d agoTACROLIMUS — FDA approvaltacrolimus ER

Sponsor: BIOCON PHARMA. Form: CAPSULE. Route: ORAL

full page →tacrolimus ER →fda approvals ↗

Nov 11, 2020approval2100d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Nov 11, 2020approval2100d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Nov 11, 2020approval2100d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

full page →BUPROPION HYDROCHLORIDE →fda approvals ↗

Nov 12, 2020approval2099d agoDIGOXIN — FDA approvalHikma Pharmaceuticals USA Inc

Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 12, 2020approval2099d agoDIGOXIN — FDA approvalHikma Pharmaceuticals USA Inc

Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 12, 2020approval2099d agoDIGOXIN — FDA approvalHikma Pharmaceuticals USA Inc

Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 12, 2020approval2099d agoDIGOXIN — FDA approvalHikma Pharmaceuticals USA Inc

Sponsor: IMPAX LABS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Nov 13, 2020approval2098d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗

Nov 13, 2020approval2098d agoVIGABATRIN — FDA approvalVIGABATRIN

Sponsor: ACCORD HLTHCARE. Form: FOR SOLUTION. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

Nov 13, 2020approval2098d agoOMEPRAZOLE — FDA approvalomeprazole DR

Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

full page →omeprazole DR →fda approvals ↗

Week of Nov 16, 2020

Nov 16, 2020approval2095d agoZENATANE (ISOTRETINOIN) — FDA approvalISOTRETINOIN

Sponsor: DR REDDYS LABS LTD. Form: CAPSULE. Route: ORAL

full page →ISOTRETINOIN →fda approvals ↗

Nov 17, 2020approval

Week of Nov 23, 2020

Nov 23, 2020approval2088d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION

full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗

Nov 24, 2020approval

Week of Nov 30, 2020

Nov 30, 2020approval2081d agoCHILDREN'S ZYRTEC ALLERGY (CETIRIZINE HYDROCHLORIDE) — FDA approvalKenvue Inc.

Sponsor: KENVUE BRANDS. Form: TABLET, CHEWABLE. Route: ORAL

full page →fda approvals ↗

Nov 30, 2020approval

← prev

page 53 of 590

Week of Nov 9, 2020

Week of Nov 16, 2020

Week of Nov 23, 2020

Week of Nov 30, 2020